Download presentation
Presentation is loading. Please wait.
Published byAlberta Hall Modified over 9 years ago
1
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation. Education in Palliative and End-of-life Care - Oncology The Project EPEC-O TM
2
EPECEPECOOEPECEPECOOO EPECEPECOOEPECEPECOOO Module 3q Symptoms – Skin Module 3q Symptoms – Skin EPEC – Oncology Education in Palliative and End-of-life Care – Oncology
3
Skin wounds... l Acute vs. chronic; likely to heal or not l Chemotherapy agent extravasation l Radiation damage l Decubitus ulcers l Malignant wounds l Acute vs. chronic; likely to heal or not l Chemotherapy agent extravasation l Radiation damage l Decubitus ulcers l Malignant wounds
4
... Skin wounds Associated with l Pain l Depression l Anxiety l Poorer interpersonal interactions Associated with l Pain l Depression l Anxiety l Poorer interpersonal interactions
5
Key points 1.Pathophysiology 2.Assessment 3.Management 1.Pathophysiology 2.Assessment 3.Management
6
Skin symptoms l Organ system l Highly innervated l Visible l Psychological, social, and spiritual l Interdisciplinary care l Symptom control l Organ system l Highly innervated l Visible l Psychological, social, and spiritual l Interdisciplinary care l Symptom control
7
Chemotherapy extravasation: pathophysiology l Acute wound l Products of inflammation RednessSwellingPain l Cell death Necrosis, open wound l Acute wound l Products of inflammation RednessSwellingPain l Cell death Necrosis, open wound
8
Radiation: pathophysiology l Radiation damage l Acute wound l Products of inflammation l Cell death l Radiation damage l Acute wound l Products of inflammation l Cell death
9
Decubitus ulcers: pathophysiology l Pathophysiology Ischemia l Fat is protective l Pathophysiology Ischemia l Fat is protective
10
Malignant wounds: pathophysiology l Disrupted physiology l Products of inflammation l Neovascularization Bleeding l Necrosis Anaerobic and fungal infections l Disrupted physiology l Products of inflammation l Neovascularization Bleeding l Necrosis Anaerobic and fungal infections
11
Assessment... l Acute versus chronic l By wound type l Acute versus chronic l By wound type
12
Chemotherapy extravasation: assessment l Type of chemotherapy Vesicant, eg, doxorubicin Irritant, eg, carmustine Non-irritants, eg, fluorouracil l Extent Volume of extravasation and time Seconds, minutes, hours l Involved anatomy l Type of chemotherapy Vesicant, eg, doxorubicin Irritant, eg, carmustine Non-irritants, eg, fluorouracil l Extent Volume of extravasation and time Seconds, minutes, hours l Involved anatomy
13
Radiation: assessment l Radiation sensitizers Topical agents Drugs, including chemotherapy l Dose and fractionation schedule Expected course l Radiation sensitizers Topical agents Drugs, including chemotherapy l Dose and fractionation schedule Expected course
14
Decubitus ulcers l Assessment Risk factors l Prevention Skin protection – shear / tear / moisture Pressure reduction and pressure relief l Assessment Risk factors l Prevention Skin protection – shear / tear / moisture Pressure reduction and pressure relief
15
Decubitus ulcers: staging 1.Non-blanchable erythema 2.Partial-thickness skin loss 3.Full-thickness skin loss 4.Extensive necrosis exposing muscle or bone 1.Non-blanchable erythema 2.Partial-thickness skin loss 3.Full-thickness skin loss 4.Extensive necrosis exposing muscle or bone
16
Management l Acute versus chronic l By wound type l Acute versus chronic l By wound type
17
Necrotic wound: management l Debridement Surgical Enzymes and gels Mechanical Pain control l Cleansing l Debridement Surgical Enzymes and gels Mechanical Pain control l Cleansing
18
Chemotherapy extravasation: management l Contain damage Stop infusion Neutralize l Assess for surgical consultation l Watch and wait l Contain damage Stop infusion Neutralize l Assess for surgical consultation l Watch and wait
19
Radiation: management l Promote healing Avoid cytotoxic agents Moist environment Treat infection Pain control l Promote healing Avoid cytotoxic agents Moist environment Treat infection Pain control
20
Decubitus ulcers: management l Goals: healing vs non-healing l Healing Debridement Dressings that promote healing l Non-healing Pain control, comfort Prevent worsening l Goals: healing vs non-healing l Healing Debridement Dressings that promote healing l Non-healing Pain control, comfort Prevent worsening
21
l Moist, interactive environment l Control infection l 6 types of dressing FoamsAlginatesHydrogelsHydrocolloids Thin films Cotton gauze l Moist, interactive environment l Control infection l 6 types of dressing FoamsAlginatesHydrogelsHydrocolloids Thin films Cotton gauze Decubitus ulcers: dressing
22
Malignant wounds: management l Healing vs non-healing l Infections l Odors l Pain l Exudate l Bleeding l Healing vs non-healing l Infections l Odors l Pain l Exudate l Bleeding
23
Odors l Topical and / or systemic antibiotics Metronidazole Silver sulfadiazine l Kitty litter l Activated charcoal l Vinegar l Burning candles l Topical and / or systemic antibiotics Metronidazole Silver sulfadiazine l Kitty litter l Activated charcoal l Vinegar l Burning candles
24
EPECEPECOOEPECEPECOOO EPECEPECOOEPECEPECOOO Summary Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.